Certified CME provider: Excerpta Medica

Share this article:
Company Profile
Excerpta Medica Inc., an Elsevier business, is a global medical communications company headquartered in the US and The Netherlands. Since 1946, Excerpta Medica (www.excerptamedica.com) has been partnering with its clients in the pharmaceutical and biotech industries to ensure healthcare professionals will have the information they need to make informed decisions regarding treatment options for their patients. As part of Elsevier, the world's largest medical and scientific publisher, Excerpta Medica leverages Elsevier's many resources to build unique and powerful medical communications solutions.

Services and Offerings
The team of professionals at Excerpta Medica think, create and deliver a full line of strategic solutions in the areas of:

Strategic Publications Planning
Excerpta Medica develops and implements strategic publications plans, and provides expertise in scientific writing, abstracts and poster development for scientific congresses, and gap and competitor analysis.

Medical Education
We deliver a range of strategic, scientific and creative communications solutions including satellite symposia, teleconferences, advisory board meetings, investigator training meetings, slide kits, KOL development programs and e-media.

Custom and Medical Publishing
With a variety of publication solutions ranging from rapid, peer-reviewed titles such as Clinical Therapeutics and The American Journal of Geriatric Pharmacotherapy, to industry-sponsored publications like Clinical Cornerstone, we leverage Elsevier's well-known book and journal titles to create customized solutions based on specific client and target audience needs.

Interactive Solutions
Our award-winning team at Excerpta Medica Interactive creates and implements innovative online medical communications solutions that successfully drive clients' educational strategies. We achieve our clients' goals by creating innovative, intuitive and interactive solutions for the world's leading healthcare brands.
Share this article:

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"